MVA85A

WikiDoc Resources for MVA85A
Articles
Most recent articles on MVA85A Most cited articles on MVA85A Review articles on MVA85A Articles on MVA85A in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on MVA85A Images of MVA85A Photos of MVA85A Podcasts & MP3s on MVA85A Videos on MVA85A
Evidence Based Medicine
Cochrane Collaboration on MVA85A Bandolier on MVA85A TRIP on MVA85A
Clinical Trials
Ongoing Trials on MVA85A at Clinical Trials.gov Trial results on MVA85A Clinical Trials on MVA85A at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on MVA85A NICE Guidance on MVA85A NHS PRODIGY Guidance FDA on MVA85A CDC on MVA85A
Books
Books on MVA85A
News
MVA85A in the news Be alerted to news on MVA85A News trends on MVA85A
Commentary
Blogs on MVA85A
Definitions
Definitions of MVA85A
Patient Resources / Community
Patient resources on MVA85A Discussion groups on MVA85A Patient Handouts on MVA85A Directions to Hospitals Treating MVA85A Risk calculators and risk factors for MVA85A
Healthcare Provider Resources
Symptoms of MVA85A Causes & Risk Factors for MVA85A Diagnostic studies for MVA85A Treatment of MVA85A
Continuing Medical Education (CME)
CME Programs on MVA85A
International
MVA85A en Espanol MVA85A en Francais
Business
MVA85A in the Marketplace Patents on MVA85A
Experimental / Informatics
List of terms related to MVA85A

MVA85A (modified vaccinia Ankara 85A) is a new-generation vaccine against tuberculosis developed by researchers at Oxford University. This vaccine produces higher levels of long-lasting cellular immunity when used together with the old TB vaccine called BCG. Phase I clinical trials have been completed and phase II clinical trials are currently underway in South Africa with the aim of achieving a product licence by 2010.

External links

• New TB vaccine shown to be safe

References

Template:WikiDoc Sources